MovDisordV3, PascalFrancis, Corpus, bibRecord, 001D95

Direct comparison between regional cerebral metabolism in progressive supranuclear palsy and Parkinson's disease

Identifieur interne : 001D95 ( PascalFrancis/Corpus ); précédent : 001D94; suivant : 001D96

Direct comparison between regional cerebral metabolism in progressive supranuclear palsy and Parkinson's disease

Auteurs : Reinoud C. Klein ; Bauke M. De Jong ; Joeke J. De Vries ; Klaus L. Leenders

Source :

Movement disorders [ 0885-3185 ] ; 2005.

RBID : Pascal:05-0444130

Descripteurs français

Pascal (Inist)
- Système nerveux pathologie, Infirmité motrice cérébrale, Parkinson maladie, Hallucination, Etude comparative, Métabolisme, Tomoscintigraphie, Positon, Tomographie émission positon, Frontal.

English descriptors

KwdEn :
- Cerebral palsy, Comparative study, Emission tomography, Frontal, Hallucination, Metabolism, Nervous system diseases, Parkinson disease, Positron, Positron emission tomography.

Abstract

The differentiation between progressive supranuclear palsy (PSP) and Parkinson's disease (PD) may be difficult, especially in the early stages of disease. Positron emission tomography potentially provides a tool for making such a distinction. To identify key features in the spatial distributions of cerebral glucose metabolism, ¹⁸F-fluorodeoxyglucose (FDG) measurements of 10 patients with probable or possible PSP were directly compared with those of 9 PD patients. This analysis was done with statistic parametric mapping. After normalization of global brain uptake, in PSP, relative uptake of FDG was reduced in the caudal (motor) part of the anterior cingulate gyrus (Brodmann's area BA 24; P < 0.05, corrected for multiple comparisons). At a lower threshold, an additional decrease was present in the dorsal mesencephalon. In PD, relative hypometabolism was seen in extrastriate visual, ventrolateral temporal, posterior parietal, and orbitofrontal regions. Only reduction in the right fusiform gyrus and the lateral extrastriate visual cortex reached statistical significance. We concluded that particularly the reduction of medial frontal metabolism may be a valuable diagnostic imaging parameter in distinguishing PSP from PD. For PD, a possible association between occipitotemporal FDG decrease and vulnerability to hallucinations is suggested.

Notice en format standard (ISO 2709)

Pour connaître la documentation sur le format Inist Standard.

A01	`01`	`1`		`@0 0885-3185`
A03		`1`		`@0 Mov. disord.`
A05				`@2 20`
A06				`@2 8`
A08	`01`	`1`	`ENG`	`@1 Direct comparison between regional cerebral metabolism in progressive supranuclear palsy and Parkinson's disease`
A11	`01`	`1`		`@1 KLEIN (Reinoud C.)`
A11	`02`	`1`		`@1 DE JONG (Bauke M.)`
A11	`03`	`1`		`@1 DE VRIES (Joeke J.)`
A11	`04`	`1`		`@1 LEENDERS (Klaus L.)`
A14	`01`			`@1 Department of Neurology, University Hospital Groningen @3 NLD @Z 1 aut. @Z 2 aut. @Z 3 aut. @Z 4 aut.`
A14	`02`			`@1 PET Center, University Hospital Groningen @3 NLD @Z 2 aut.`
A20				`@1 1021-1030`
A21				`@1 2005`
A23	`01`			`@0 ENG`
A43	`01`			`@1 INIST @2 20953 @5 354000132711360170`
A44				`@0 0000 @1 © 2005 INIST-CNRS. All rights reserved.`
A45				`@0 46 ref.`
A47	`01`	`1`		`@0 05-0444130`
A60				`@1 P`
A61				`@0 A`
A64	`01`	`1`		`@0 Movement disorders`
A66	`01`			`@0 USA`
C01	`01`		`ENG`	@0 The differentiation between progressive supranuclear palsy (PSP) and Parkinson's disease (PD) may be difficult, especially in the early stages of disease. Positron emission tomography potentially provides a tool for making such a distinction. To identify key features in the spatial distributions of cerebral glucose metabolism, ¹⁸F-fluorodeoxyglucose (FDG) measurements of 10 patients with probable or possible PSP were directly compared with those of 9 PD patients. This analysis was done with statistic parametric mapping. After normalization of global brain uptake, in PSP, relative uptake of FDG was reduced in the caudal (motor) part of the anterior cingulate gyrus (Brodmann's area BA 24; P < 0.05, corrected for multiple comparisons). At a lower threshold, an additional decrease was present in the dorsal mesencephalon. In PD, relative hypometabolism was seen in extrastriate visual, ventrolateral temporal, posterior parietal, and orbitofrontal regions. Only reduction in the right fusiform gyrus and the lateral extrastriate visual cortex reached statistical significance. We concluded that particularly the reduction of medial frontal metabolism may be a valuable diagnostic imaging parameter in distinguishing PSP from PD. For PD, a possible association between occipitotemporal FDG decrease and vulnerability to hallucinations is suggested.
C02	`01`	`X`		`@0 002B17`
C02	`02`	`X`		`@0 002B17G`
C02	`03`	`X`		`@0 002B17C`
C03	`01`	`X`	`FRE`	`@0 Système nerveux pathologie @5 01`
C03	`01`	`X`	`ENG`	`@0 Nervous system diseases @5 01`
C03	`01`	`X`	`SPA`	`@0 Sistema nervioso patología @5 01`
C03	`02`	`X`	`FRE`	`@0 Infirmité motrice cérébrale @5 02`
C03	`02`	`X`	`ENG`	`@0 Cerebral palsy @5 02`
C03	`02`	`X`	`SPA`	`@0 Encefalopatía infantil @5 02`
C03	`03`	`X`	`FRE`	`@0 Parkinson maladie @5 03`
C03	`03`	`X`	`ENG`	`@0 Parkinson disease @5 03`
C03	`03`	`X`	`SPA`	`@0 Parkinson enfermedad @5 03`
C03	`04`	`X`	`FRE`	`@0 Hallucination @5 04`
C03	`04`	`X`	`ENG`	`@0 Hallucination @5 04`
C03	`04`	`X`	`SPA`	`@0 Alucinación @5 04`
C03	`05`	`X`	`FRE`	`@0 Etude comparative @5 09`
C03	`05`	`X`	`ENG`	`@0 Comparative study @5 09`
C03	`05`	`X`	`SPA`	`@0 Estudio comparativo @5 09`
C03	`06`	`X`	`FRE`	`@0 Métabolisme @5 10`
C03	`06`	`X`	`ENG`	`@0 Metabolism @5 10`
C03	`06`	`X`	`SPA`	`@0 Metabolismo @5 10`
C03	`07`	`X`	`FRE`	`@0 Tomoscintigraphie @5 11`
C03	`07`	`X`	`ENG`	`@0 Emission tomography @5 11`
C03	`07`	`X`	`SPA`	`@0 Tomocentelleografía @5 11`
C03	`08`	`X`	`FRE`	`@0 Positon @5 12`
C03	`08`	`X`	`ENG`	`@0 Positron @5 12`
C03	`08`	`X`	`SPA`	`@0 Positrón @5 12`
C03	`09`	`X`	`FRE`	`@0 Tomographie émission positon @5 13`
C03	`09`	`X`	`ENG`	`@0 Positron emission tomography @5 13`
C03	`09`	`X`	`SPA`	`@0 Tomografía emisión positrones @5 13`
C03	`10`	`X`	`FRE`	`@0 Frontal @5 14`
C03	`10`	`X`	`ENG`	`@0 Frontal @5 14`
C03	`10`	`X`	`SPA`	`@0 Frontal @5 14`
C07	`01`	`X`	`FRE`	`@0 Encéphale pathologie @5 37`
C07	`01`	`X`	`ENG`	`@0 Cerebral disorder @5 37`
C07	`01`	`X`	`SPA`	`@0 Encéfalo patología @5 37`
C07	`02`	`X`	`FRE`	`@0 Système nerveux central pathologie @5 38`
C07	`02`	`X`	`ENG`	`@0 Central nervous system disease @5 38`
C07	`02`	`X`	`SPA`	`@0 Sistema nervosio central patología @5 38`
C07	`03`	`X`	`FRE`	`@0 Extrapyramidal syndrome @5 39`
C07	`03`	`X`	`ENG`	`@0 Extrapyramidal syndrome @5 39`
C07	`03`	`X`	`SPA`	`@0 Extrapiramidal síndrome @5 39`
C07	`04`	`X`	`FRE`	`@0 Maladie dégénérative @5 40`
C07	`04`	`X`	`ENG`	`@0 Degenerative disease @5 40`
C07	`04`	`X`	`SPA`	`@0 Enfermedad degenerativa @5 40`
N21				`@1 311`
N44	`01`			`@1 OTO`
N82				`@1 OTO`

Format Inist (serveur)

NO :	PASCAL 05-0444130 INIST
ET :	Direct comparison between regional cerebral metabolism in progressive supranuclear palsy and Parkinson's disease
AU :	KLEIN (Reinoud C.); DE JONG (Bauke M.); DE VRIES (Joeke J.); LEENDERS (Klaus L.)
AF :	Department of Neurology, University Hospital Groningen/Pays-Bas (1 aut., 2 aut., 3 aut., 4 aut.); PET Center, University Hospital Groningen/Pays-Bas (2 aut.)
DT :	Publication en série; Niveau analytique
SO :	Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 2005; Vol. 20; No. 8; Pp. 1021-1030; Bibl. 46 ref.
LA :	Anglais
EA :	The differentiation between progressive supranuclear palsy (PSP) and Parkinson's disease (PD) may be difficult, especially in the early stages of disease. Positron emission tomography potentially provides a tool for making such a distinction. To identify key features in the spatial distributions of cerebral glucose metabolism, ¹⁸F-fluorodeoxyglucose (FDG) measurements of 10 patients with probable or possible PSP were directly compared with those of 9 PD patients. This analysis was done with statistic parametric mapping. After normalization of global brain uptake, in PSP, relative uptake of FDG was reduced in the caudal (motor) part of the anterior cingulate gyrus (Brodmann's area BA 24; P < 0.05, corrected for multiple comparisons). At a lower threshold, an additional decrease was present in the dorsal mesencephalon. In PD, relative hypometabolism was seen in extrastriate visual, ventrolateral temporal, posterior parietal, and orbitofrontal regions. Only reduction in the right fusiform gyrus and the lateral extrastriate visual cortex reached statistical significance. We concluded that particularly the reduction of medial frontal metabolism may be a valuable diagnostic imaging parameter in distinguishing PSP from PD. For PD, a possible association between occipitotemporal FDG decrease and vulnerability to hallucinations is suggested.
CC :	002B17; 002B17G; 002B17C
FD :	Système nerveux pathologie; Infirmité motrice cérébrale; Parkinson maladie; Hallucination; Etude comparative; Métabolisme; Tomoscintigraphie; Positon; Tomographie émission positon; Frontal
FG :	Encéphale pathologie; Système nerveux central pathologie; Extrapyramidal syndrome; Maladie dégénérative
ED :	Nervous system diseases; Cerebral palsy; Parkinson disease; Hallucination; Comparative study; Metabolism; Emission tomography; Positron; Positron emission tomography; Frontal
EG :	Cerebral disorder; Central nervous system disease; Extrapyramidal syndrome; Degenerative disease
SD :	Sistema nervioso patología; Encefalopatía infantil; Parkinson enfermedad; Alucinación; Estudio comparativo; Metabolismo; Tomocentelleografía; Positrón; Tomografía emisión positrones; Frontal
LO :	INIST-20953.354000132711360170
ID :	05-0444130

Links to Exploration step

Pascal:05-0444130

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Direct comparison between regional cerebral metabolism in progressive supranuclear palsy and Parkinson's disease</title>
<author><name sortKey="Klein, Reinoud C" sort="Klein, Reinoud C" uniqKey="Klein R" first="Reinoud C." last="Klein">Reinoud C. Klein</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Neurology, University Hospital Groningen</s1>
<s3>NLD</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="De Jong, Bauke M" sort="De Jong, Bauke M" uniqKey="De Jong B" first="Bauke M." last="De Jong">Bauke M. De Jong</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Neurology, University Hospital Groningen</s1>
<s3>NLD</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="02"><s1>PET Center, University Hospital Groningen</s1>
<s3>NLD</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="De Vries, Joeke J" sort="De Vries, Joeke J" uniqKey="De Vries J" first="Joeke J." last="De Vries">Joeke J. De Vries</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Neurology, University Hospital Groningen</s1>
<s3>NLD</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Leenders, Klaus L" sort="Leenders, Klaus L" uniqKey="Leenders K" first="Klaus L." last="Leenders">Klaus L. Leenders</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Neurology, University Hospital Groningen</s1>
<s3>NLD</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">05-0444130</idno>
<date when="2005">2005</date>
<idno type="stanalyst">PASCAL 05-0444130 INIST</idno>
<idno type="RBID">Pascal:05-0444130</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">001D95</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Direct comparison between regional cerebral metabolism in progressive supranuclear palsy and Parkinson's disease</title>
<author><name sortKey="Klein, Reinoud C" sort="Klein, Reinoud C" uniqKey="Klein R" first="Reinoud C." last="Klein">Reinoud C. Klein</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Neurology, University Hospital Groningen</s1>
<s3>NLD</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="De Jong, Bauke M" sort="De Jong, Bauke M" uniqKey="De Jong B" first="Bauke M." last="De Jong">Bauke M. De Jong</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Neurology, University Hospital Groningen</s1>
<s3>NLD</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="02"><s1>PET Center, University Hospital Groningen</s1>
<s3>NLD</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="De Vries, Joeke J" sort="De Vries, Joeke J" uniqKey="De Vries J" first="Joeke J." last="De Vries">Joeke J. De Vries</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Neurology, University Hospital Groningen</s1>
<s3>NLD</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Leenders, Klaus L" sort="Leenders, Klaus L" uniqKey="Leenders K" first="Klaus L." last="Leenders">Klaus L. Leenders</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Neurology, University Hospital Groningen</s1>
<s3>NLD</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="2005">2005</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Cerebral palsy</term>
<term>Comparative study</term>
<term>Emission tomography</term>
<term>Frontal</term>
<term>Hallucination</term>
<term>Metabolism</term>
<term>Nervous system diseases</term>
<term>Parkinson disease</term>
<term>Positron</term>
<term>Positron emission tomography</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Système nerveux pathologie</term>
<term>Infirmité motrice cérébrale</term>
<term>Parkinson maladie</term>
<term>Hallucination</term>
<term>Etude comparative</term>
<term>Métabolisme</term>
<term>Tomoscintigraphie</term>
<term>Positon</term>
<term>Tomographie émission positon</term>
<term>Frontal</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The differentiation between progressive supranuclear palsy (PSP) and Parkinson's disease (PD) may be difficult, especially in the early stages of disease. Positron emission tomography potentially provides a tool for making such a distinction. To identify key features in the spatial distributions of cerebral glucose metabolism, <sup>18</sup>
F-fluorodeoxyglucose (FDG) measurements of 10 patients with probable or possible PSP were directly compared with those of 9 PD patients. This analysis was done with statistic parametric mapping. After normalization of global brain uptake, in PSP, relative uptake of FDG was reduced in the caudal (motor) part of the anterior cingulate gyrus (Brodmann's area BA 24; P < 0.05, corrected for multiple comparisons). At a lower threshold, an additional decrease was present in the dorsal mesencephalon. In PD, relative hypometabolism was seen in extrastriate visual, ventrolateral temporal, posterior parietal, and orbitofrontal regions. Only reduction in the right fusiform gyrus and the lateral extrastriate visual cortex reached statistical significance. We concluded that particularly the reduction of medial frontal metabolism may be a valuable diagnostic imaging parameter in distinguishing PSP from PD. For PD, a possible association between occipitotemporal FDG decrease and vulnerability to hallucinations is suggested.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0885-3185</s0>
</fA01>
<fA03 i2="1"><s0>Mov. disord.</s0>
</fA03>
<fA05><s2>20</s2>
</fA05>
<fA06><s2>8</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Direct comparison between regional cerebral metabolism in progressive supranuclear palsy and Parkinson's disease</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>KLEIN (Reinoud C.)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>DE JONG (Bauke M.)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>DE VRIES (Joeke J.)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>LEENDERS (Klaus L.)</s1>
</fA11>
<fA14 i1="01"><s1>Department of Neurology, University Hospital Groningen</s1>
<s3>NLD</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>PET Center, University Hospital Groningen</s1>
<s3>NLD</s3>
<sZ>2 aut.</sZ>
</fA14>
<fA20><s1>1021-1030</s1>
</fA20>
<fA21><s1>2005</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>20953</s2>
<s5>354000132711360170</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2005 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>46 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>05-0444130</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Movement disorders</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>The differentiation between progressive supranuclear palsy (PSP) and Parkinson's disease (PD) may be difficult, especially in the early stages of disease. Positron emission tomography potentially provides a tool for making such a distinction. To identify key features in the spatial distributions of cerebral glucose metabolism, <sup>18</sup>
F-fluorodeoxyglucose (FDG) measurements of 10 patients with probable or possible PSP were directly compared with those of 9 PD patients. This analysis was done with statistic parametric mapping. After normalization of global brain uptake, in PSP, relative uptake of FDG was reduced in the caudal (motor) part of the anterior cingulate gyrus (Brodmann's area BA 24; P < 0.05, corrected for multiple comparisons). At a lower threshold, an additional decrease was present in the dorsal mesencephalon. In PD, relative hypometabolism was seen in extrastriate visual, ventrolateral temporal, posterior parietal, and orbitofrontal regions. Only reduction in the right fusiform gyrus and the lateral extrastriate visual cortex reached statistical significance. We concluded that particularly the reduction of medial frontal metabolism may be a valuable diagnostic imaging parameter in distinguishing PSP from PD. For PD, a possible association between occipitotemporal FDG decrease and vulnerability to hallucinations is suggested.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B17</s0>
</fC02>
<fC02 i1="02" i2="X"><s0>002B17G</s0>
</fC02>
<fC02 i1="03" i2="X"><s0>002B17C</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Système nerveux pathologie</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Nervous system diseases</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Sistema nervioso patología</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Infirmité motrice cérébrale</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Cerebral palsy</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Encefalopatía infantil</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Parkinson maladie</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Parkinson disease</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Parkinson enfermedad</s0>
<s5>03</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Hallucination</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Hallucination</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Alucinación</s0>
<s5>04</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Etude comparative</s0>
<s5>09</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Comparative study</s0>
<s5>09</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Estudio comparativo</s0>
<s5>09</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Métabolisme</s0>
<s5>10</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Metabolism</s0>
<s5>10</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Metabolismo</s0>
<s5>10</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Tomoscintigraphie</s0>
<s5>11</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Emission tomography</s0>
<s5>11</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Tomocentelleografía</s0>
<s5>11</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE"><s0>Positon</s0>
<s5>12</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG"><s0>Positron</s0>
<s5>12</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA"><s0>Positrón</s0>
<s5>12</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE"><s0>Tomographie émission positon</s0>
<s5>13</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG"><s0>Positron emission tomography</s0>
<s5>13</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA"><s0>Tomografía emisión positrones</s0>
<s5>13</s5>
</fC03>
<fC03 i1="10" i2="X" l="FRE"><s0>Frontal</s0>
<s5>14</s5>
</fC03>
<fC03 i1="10" i2="X" l="ENG"><s0>Frontal</s0>
<s5>14</s5>
</fC03>
<fC03 i1="10" i2="X" l="SPA"><s0>Frontal</s0>
<s5>14</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Encéphale pathologie</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Cerebral disorder</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Encéfalo patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Système nerveux central pathologie</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Central nervous system disease</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Sistema nervosio central patología</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Extrapyramidal syndrome</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Extrapyramidal syndrome</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Extrapiramidal síndrome</s0>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Maladie dégénérative</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Degenerative disease</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Enfermedad degenerativa</s0>
<s5>40</s5>
</fC07>
<fN21><s1>311</s1>
</fN21>
<fN44 i1="01"><s1>OTO</s1>
</fN44>
<fN82><s1>OTO</s1>
</fN82>
</pA>
</standard>
<server><NO>PASCAL 05-0444130 INIST</NO>
<ET>Direct comparison between regional cerebral metabolism in progressive supranuclear palsy and Parkinson's disease</ET>
<AU>KLEIN (Reinoud C.); DE JONG (Bauke M.); DE VRIES (Joeke J.); LEENDERS (Klaus L.)</AU>
<AF>Department of Neurology, University Hospital Groningen/Pays-Bas (1 aut., 2 aut., 3 aut., 4 aut.); PET Center, University Hospital Groningen/Pays-Bas (2 aut.)</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 2005; Vol. 20; No. 8; Pp. 1021-1030; Bibl. 46 ref.</SO>
<LA>Anglais</LA>
<EA>The differentiation between progressive supranuclear palsy (PSP) and Parkinson's disease (PD) may be difficult, especially in the early stages of disease. Positron emission tomography potentially provides a tool for making such a distinction. To identify key features in the spatial distributions of cerebral glucose metabolism, <sup>18</sup>
F-fluorodeoxyglucose (FDG) measurements of 10 patients with probable or possible PSP were directly compared with those of 9 PD patients. This analysis was done with statistic parametric mapping. After normalization of global brain uptake, in PSP, relative uptake of FDG was reduced in the caudal (motor) part of the anterior cingulate gyrus (Brodmann's area BA 24; P < 0.05, corrected for multiple comparisons). At a lower threshold, an additional decrease was present in the dorsal mesencephalon. In PD, relative hypometabolism was seen in extrastriate visual, ventrolateral temporal, posterior parietal, and orbitofrontal regions. Only reduction in the right fusiform gyrus and the lateral extrastriate visual cortex reached statistical significance. We concluded that particularly the reduction of medial frontal metabolism may be a valuable diagnostic imaging parameter in distinguishing PSP from PD. For PD, a possible association between occipitotemporal FDG decrease and vulnerability to hallucinations is suggested.</EA>
<CC>002B17; 002B17G; 002B17C</CC>
<FD>Système nerveux pathologie; Infirmité motrice cérébrale; Parkinson maladie; Hallucination; Etude comparative; Métabolisme; Tomoscintigraphie; Positon; Tomographie émission positon; Frontal</FD>
<FG>Encéphale pathologie; Système nerveux central pathologie; Extrapyramidal syndrome; Maladie dégénérative</FG>
<ED>Nervous system diseases; Cerebral palsy; Parkinson disease; Hallucination; Comparative study; Metabolism; Emission tomography; Positron; Positron emission tomography; Frontal</ED>
<EG>Cerebral disorder; Central nervous system disease; Extrapyramidal syndrome; Degenerative disease</EG>
<SD>Sistema nervioso patología; Encefalopatía infantil; Parkinson enfermedad; Alucinación; Estudio comparativo; Metabolismo; Tomocentelleografía; Positrón; Tomografía emisión positrones; Frontal</SD>
<LO>INIST-20953.354000132711360170</LO>
<ID>05-0444130</ID>
</server>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001D95 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 001D95 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    PascalFrancis
   |étape=   Corpus
   |type=    RBID
   |clé=     Pascal:05-0444130
   |texte=   Direct comparison between regional cerebral metabolism in progressive supranuclear palsy and Parkinson's disease
}}

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Movement Disorders (revue)

Direct comparison between regional cerebral metabolism in progressive supranuclear palsy and Parkinson's disease

Direct comparison between regional cerebral metabolism in progressive supranuclear palsy and Parkinson's disease

Source :

Descripteurs français

English descriptors

Abstract

Notice en format standard (ISO 2709)

Format Inist (serveur)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri